Two investment banks have been named as advisers to private equity firms PPM Capital and Triton Advisers as the firms look to sell Swedish healthcare company Phadia.

Morgan Stanley and UBS were appointed by the buyout firms, who are seeking more than €1bn ($1.3bn) for the company, which manufactures test kits for allergies and diseases. They won the mandate ahead of rivals Rothschild and Citigroup.